Real-time enrollment status for this ganglioneuroblastoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:44 AM UTC
| NCT Number | NCT03126916 |
| Recruiting Status | Recruiting |
| Condition | Ganglioneuroblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 750 participants |
| Active Locations | 152 sites in the US |
| Sponsor | Children's Oncology Group |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 13, 2026: Clinical trial NCT03126916 is currently recruiting participants. This clinical trial study for ganglioneuroblastoma is actively seeking new participants at 152 locations across the United States. The study is sponsored by Children's Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03126916 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 152 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03126916 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.